COST given budget boost for FP7

COST, the European Cooperation in Science and Technology, will continue to be managed by the European Science Foundation (ESF) under the Seventh Framework Programme (FP7). The European Commission and ESF signed a contract to this effect at the end of July.

Under the Sixth Framework Programme (FP6), EU support for COST amounted to €80 million, a figure which is set to rise to €210 million under FP7. An additional €40 million could be added to the pot if a mid-term evaluation in 2010 is successful.

"The contract and the increase in funding is indeed a strong vote of confidence towards the ESF-COST cooperation," said Dr Martin Grabert, Director of the COST Office. "With this contract, we can truly capitalise on previous successes. We will not rest on our laurels, however, and continue to focus on cross-disciplinary initiatives and strengthening the synergy between the various research actors in Europe."

The bigger budget will allow COST to expand its activities and boost support for both the scientific and technical committees and the COST Actions (networks of researchers).

The contract sets out a series of work packages which reflect the increase in funding through new and expanded activities, the development of new ideas for interdisciplinary science initiatives and a greater exploitation of the European 'Near Neighbours' policy. There is also a stronger focus on outreach and communications.

"The negotiation of this contract and the transition between FP6 and FP7 were two challenging processes," commented David Weber, the ESF's Director of Administration and Finance, noting that the ESF's commitment to COST, coupled with its experience of managing such a complex operation, had been key to the successful completion of the agreement.

"I very much welcome the positive conclusion of the negotiations for the signature of the EC-ESF contract for COST," added Professor Francesco Fedi, President of the COST Committee of Senior Officials. "COST has always been a unique instrument with a strong role to play towards the development of the ERA. Typical COST features such as its flexibility and bottom-up approach make it a perfect platform for innovative ideas on the frontiers of science."

A recent independent review of the Commission-ESF COST contract for FP6 noted the high levels of satisfaction among users of COST and concluded that the switchover from the COST Action managed by the European to the COST Office run by the ESF had been largely successful.

Established in 1971, COST is now used by researchers in 35 European countries to cooperate in common research projects supported by national funds.

For more information, please visit:

Copyright ©European Communities, 2007
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

AI Tool Helps Predict Who will Benefit f…

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who...

Research Shows AI Technology Improves Pa…

Existing research indicates that the accuracy of a Parkinson's disease diagnosis hovers between 55% and 78% in the first five years of assessment. That's partly because Parkinson's sibling movement disorders...

AI in Healthcare: How do We Get from Hyp…

The Highland Marketing advisory board met to consider the government's enthusiasm for AI. To date, healthcare has mostly experimented with decision support tools, and their impact on the NHS and...

New AI Tool Accelerates Disease Treatmen…

University of Virginia School of Medicine scientists have created a computational tool to accelerate the development of new disease treatments. The tool goes beyond current artificial intelligence (AI) approaches by...

Who's to Blame When AI Makes a Medi…

Assistive artificial intelligence technologies hold significant promise for transforming health care by aiding physicians in diagnosing, managing, and treating patients. However, the current trend of assistive AI implementation could actually...

First Therapy Chatbot Trial Shows AI can…

Dartmouth researchers conducted the first clinical trial of a therapy chatbot powered by generative AI and found that the software resulted in significant improvements in participants' symptoms, according to results...

DMEA sparks: The Future of Digital Healt…

8 - 10 April 2025, Berlin, Germany. Digitalization is considered one of the key strategies for addressing the shortage of skilled workers - but the digital health sector also needs qualified...

DeepSeek: The "Watson" to Doct…

DeepSeek is an artificial intelligence (AI) platform built on deep learning and natural language processing (NLP) technologies. Its core products include the DeepSeek-R1 and DeepSeek-V3 models. Leveraging an efficient Mixture...

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...